NIH-funded research R01 grant

Investigating sinus disease in young children with cystic fibrosis

Official title: Sinus Disease in Young Children with Cystic Fibrosis

Funded at University of California Los Angeles · NIH-10945299 · Data updated 2026-11-12

This study is looking at how chronic rhinosinusitis affects young children with cystic fibrosis and whether a new treatment can help improve their sinus health and sense of smell.

More Fibrosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJuly 15, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$687,448
NIH project number1R01HL174913-01
Project IDNIH-10945299 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are young children diagnosed with cystic fibrosis who are experiencing chronic rhinosinusitis.

Less likely to help

Patients who do not have cystic fibrosis or who are older than the targeted age group may not benefit from this research.

What this research studies

This research focuses on understanding how chronic rhinosinusitis (CRS) affects young children with cystic fibrosis (CF) and how their olfactory function is impacted. The study aims to evaluate the effects of highly effective CF transmembrane conductance regulator modulator therapy (HEMT) on these conditions. By observing children before and after starting HEMT, researchers hope to determine if early treatment can lead to significant improvements in sinus health and smell function. This research is particularly important as CRS can severely affect the quality of life and overall health in these young patients.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies for sinus disease and olfactory dysfunction in young children with cystic fibrosis.

How similar studies have gone: Previous research has shown that adults with cystic fibrosis experience improvements in sinus disease after starting HEMT, suggesting potential for similar benefits in younger patients.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Beswick, Daniel M — University of California Los Angeles
  • Study coordinator: Beswick, Daniel M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.